Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
Launched by UNIVERSITY OF FLORIDA · Aug 14, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of frequent and standardized oral care using human milk on very low birth weight (VLBW) infants who are in the Neonatal Intensive Care Unit (NICU). The goal is to see if this type of oral care can help prevent serious lung problems, such as pneumonia and bronchopulmonary dysplasia, which can occur in premature infants. Researchers will follow 168 infants who are born weighing less than 1500 grams and are less than 30 weeks old for four weeks after their birth.
To participate in this study, mothers need to be at least 18 years old, and their babies must meet the weight and gestational age criteria. Unfortunately, babies with certain birth defects or those who are not expected to survive more than seven days will not be eligible. Participants can expect to receive specialized oral care during their time in the NICU, which may help improve their overall health and reduce the risk of infections. This trial is currently recruiting, and it aims to provide valuable information on how to better care for these vulnerable infants.
Gender
ALL
Eligibility criteria
- Inclusion:
- • Mother ≥18 years of age
- • ≤ 30 weeks gestation
- • Born weighing ≤ 1500 grams
- Exclusion:
- • Congenital anomalies of the face, lungs, or gastrointestinal system
- • Not expected to live \> 7 days following delivery.
About University Of Florida
The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gainesville, Florida, United States
Patients applied
Trial Officials
Leslie Parker, PHD
Principal Investigator
University of Florida
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported